Where's the Promise of Biotech? Featuring Peter Kolchinsky

About this episode

Greg Dowling speaks with Peter Kolchinsky about the biotech industry and investment strategies.

In this episode of FEG’s Insight Bridge Podcast , Greg Dowling speaks with Peter Kolchinsky , Managing Partner at RA Capital. Together they delve into the drivers and details of today’s biotech industry, how to foster innovation and why Peter is optimistic about biotech’s ability to address autoimmune disorders. Peter shares RA Capital’s investment approach, which emphasizes patience, rigor and selectiveness across healthcare and life science sectors. You can find every episode of FEG Insight Bridge podcasts in one place and sign up to receive our other publications here .

People in this episode

Host: Greg Dowling

Guest: Peter Kolchinsky

Topics covered

• biotech industry
• innovation
• autoimmune disorders
• investment approach
• healthcare
• life sciences

Keywords

• biotech
• investment
• autoimmune disorders
• healthcare
• life sciences
• innovation
• RA Capital

Mentioned in this episode

Organizations: RA Capital, FEG Investment Advisors

Places: biotech

More episodes of FEG Insight Bridge

• The Trend is Your Friend: Leda Braga's Journey Through Academia, Quantitative Finance & Hedge Funds · June 5, 2026 · 59 min
• Lessons From the Ice and Beyond, with Jeremy Roenick · May 5, 2026 · 51 min
• Power Plays: An Energy Outlook from Dan Pickering · April 7, 2026 · 45 min
• Rebuilding the Machine: Featuring Eric Rosenthal · March 3, 2026 · 45 min
• Playing The Greens: Rick Rieder's Market Insights · February 3, 2026 · 41 min
• The Emperor's New Economic Model: Decoding the Forces Driving Markets in 2026 · January 6, 2026 · 39 min